Target intelligence / Profile preview

RNA, U6 small nuclear 811, pseudogene (RNU6-811P)

Target
RNU6-811P
Molecular classification
Pseudogene, Non-coding RNA-derived pseudogene
01

Overview

RNU6-811P is a pseudogene derived from U6 small nuclear RNA, the most conserved component of the spliceosomal snRNA machinery responsible for intron removal in eukaryotic pre-mRNA splicing[1][3]. While canonical U6 snRNA is essential for spliceosome function, pseudogenes like RNU6-811P are generally non-coding, do not produce functional RNA, and lack established biological function or disease relevance[2]. Many U6-derived pseudogenes exist in the human genome, likely serving as evolutionary remnants, and RNU6-811P is one of these[3]. There is no evidence that RNU6-811P acts as a therapeutic target, nor is there information linking it to drug interaction, mechanism of action, or use as a biomarker. Key points: - RNU6-811P is not a protein, enzyme, receptor, transporter, or active regulatory RNA. - It is one of many U6 snRNA-derived pseudogenes, known as genetic “back-ups” or remnants, and does not have an established role in health or disease[3]. - No indication exists that it is misspelled or an incorrect entity, but as a pseudogene, it is not a druggable or functional target[2][3].

Other names
RNU6-811PRNA, U6 snRNA pseudogene 811U6 small nuclear RNA pseudogene 811
02

Biological functions

Other (no established biological function; non-functional pseudogene)
03

Disease associations

Other (no known direct role in disease; some pseudogenes have regulatory or competing endogenous RNA (ceRNA) functions in certain cases, but this is not established for RNU6-811P)

Beyond the preview

Go deeper on RNA, U6 small nuclear 811, pseudogene (RNU6-811P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U6 small nuclear 811, pseudogene (RNU6-811P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call